Chendhore Veerappan

Dr. Chendhore Veerappan is a buy-side research analyst for Diamond Hill Capital Management, providing investment advice to the Diamond Hill Funds and other institutional investors. He specializes in researching pharmaceutical, biotechnology, and international healthcare companies. He has a PhD in Genetics, Molecular and Cellular Biology, and a PPM from KGI. He completed a postdoc at the UCLA School of Medicine and a corporate residency at Regeneron Pharmaceuticals.